The Chan Zuckerberg Initiative's recent $3 billion pledge for medical research is shining a spotlight on scientists who join together to advise science philanthropy.
Science Friday reports University of California, Davis, researchers have used gene editing to develop dairy cows that don't have horns.
Molecular autopsies may uncover genetic variants that caused death, but then again, they may not, the Atlantic writes.
In PLOS this week: genetic and environmental interactions that affect susceptibility to colorectal cancer, genetic diversity in ancient human head louse, and more.
Researchers unearth instances of horizontal gene transfer between bacteria used in making cheese, New Scientist reports.
A study appearing in Genetics of Danish high school students finds that the population of Denmark is rather homogenous.
In a new study, researchers find a genetic as well as environmental role in toddlers' picky eating.
In Science this week: approach to uncover recent changes in allele frequencies, and more.
Researchers describe using a CRISPR approach to edit the sickle cell gene in vitro, the Los Angeles Times reports.
Stanford University's John Ioannidis laments commercial influences on medical review articles at NPR.
New Australian guidelines discourage people from seeking genetic testing on their own, the Guardian reports.
In Nature this week: lack of diversity in genomic studies, and more.
IBM is to make its Watson technology available to its employees to identify what cancer treatments might work for them, the Wall Street Journal reports.
Researchers hope to increase the genetic diversity of bison in Minnesota, the Associated Press reports.
Nature News writes that efforts like ExAC are enabling researchers to call some seemingly disease-linked variants as benign.
In Genome Research this week: Sus scrofa genetic variants, translational plasticity might minimize effects of harmful mutations, and more.
A hedge fund that invested in Theranos files a lawsuit, the Wall Street Journal reports.
According to Retraction Watch, Ohio State University's Carlo Croce retracts a commentary over "irreconcilable differences with the journal editors."
At the Guardian, Jenny Rohn describes one ongoing approach to promote equality in the sciences.
In PNAS this week: mutation patterns in uterine and ovarian carcinosarcomas, deep genome sequences, and more.
A nonprofit organization is to launch a precision medicine trial for pancreatic cancers, Technology Review reports.
An agriculture company is focusing on products inspired by endophyte bacteria, Wired reports.
The Boston Globe writes that some volunteers want control or compensation for having given biological samples for research.
In PLOS this week: germline variants in prostate cancer risk genes, genome of a Zika virus from patient without neurological complications, and more.
NIH Director Francis Collins describes changes to improve clinical trials in JAMA this week.
At Science Careers, Princeton University's Julian West advises new researchers to read widely.
At Science Careers, a researcher describes how her rejuvenated postdoc science policy committee is promoting science.
Bitesize Bio's Gail Seigel offers some tips on running a low-budget lab.
The GRE isn't a good predictor of graduate school performance or productivity, according to two PLOS One studies.